![Ariel Feldstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ariel Feldstein is currently a Director at Elgia Therapeutics, Inc. He was previously a Director at Jecure Therapeutics, Inc. from 2016 to 2018.
| Sociétés | Poste | Début |
|---|---|---|
Elgia Therapeutics, Inc.
 Elgia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis | Directeur/Membre du Conseil | 01/01/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis | Commercial Services |
Elgia Therapeutics, Inc.
Elgia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
